Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AVAH · against 338 other Healthcare companies of similar size
Ranked #162 of 339 · scores higher than 51% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 50–59, including AVAH · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | AVAH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 331 reported | 9.5% | 2.3% | 95% | 30% | |
| EBITDA yieldHigher is better · 335 reported | 7.2% | 4.6% | 69% | 50% | |
| Free cash flow yieldHigher is better · 179 reported | 5.5% | -0.1% | 78% | 20% | |
| Book yieldHigher is better · 331 reported | 9.9% | 30.6% | 15% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 157 | 2.2B USD | 58 | 61 | |
| 162 | 5.24T KRW (≈$3.8B) | 57 | 60 | |
| 162 | 2.8B USD | 57 | 33 | |
| 162 | 1.8B USD | 57 | 52 | |
| 162 | 2.9B USD | 57 | 50 | |
| 162 | 41.9B SEK (≈$4.2B) | 57 | 53 | |
| 167 | 3.0B USD | 56 | 35 | |
| 167 | 2.2B CAD (≈$1.6B) | 56 | 44 | |
| 169 | 414.8B INR (≈$5.0B) | 55 | 73 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score